Related Experiment Videos

Myocardial infarction in a neonate. Lessons for neonatal and internal medicine

Werner Streif1

  • 1Ao. Univ.-Prof. Dr. Werner Streif, Medizinische Universität Innsbruck (MUI), Dept. für Kinder- und Jugendheilkunde, Pädiatrie 1, Anichstrasse 35, A - 6020 Innsbruck, Tel: +43-512-504 23600, Fax: +43-512-504 23484,

Hamostaseologie
|March 21, 2017
PubMed

Insights

Management for neonatal myocardial infarction (MI) requires individualized care, focusing on circulation support and antithrombotic therapy. Thrombolytic therapy offers potential for full myocardial function recovery in infants.

Area of Science:

  • Neonatal cardiology
  • Pediatric cardiovascular research
  • Myocardial infarction mechanisms

Background:

  • Neonatal myocardial infarction (MI) lacks evidence-based management guidelines.
  • Current strategies rely on clinical discretion, supportive care, and antithrombotic therapy.
  • Restoring vascular patency is crucial for treatment.

Observation:

  • Neonatal MI management is individualized.
  • Supportive care aims to maintain adequate circulation.
  • Antithrombotic therapy is a mainstay for restoring vascular patency.

Findings:

  • Thrombolytic therapy presents an opportunity to fully restore myocardial function in neonates.
  • The neonatal heart exhibits unique resilience.
  • Understanding neonatal cardiac cell repair mechanisms is key.

Implications:

  • Novel treatment strategies for severe MI may emerge from studying neonatal cardiac resilience.
  • Findings could inform future therapies for aging populations with cardiovascular disease.
  • Individualized treatment approaches are essential in neonatal cardiology.

Keywords:
Alteplase Für die Behandlung des Herzinfarkts beim Neugeborenen gibt es keine auf Evidenz beruhende Empfehlung. Die Behandlung muss individuell gestaltet werden und obliegt weitestgehend dem jeweiligen Behandlungsteam. Die Behandlung besteht aus supportiven Maßnahmen und antithrombotischen Medikamenten mit dem Ziel der Wiedereröffnung verschlossener Gefäße. Eine Thrombolyse mit Alteplase birgt beim Neugeborenen die Chance einer vollständigen Erholung der Herzfunktion. Das bessere Verständnis der außerordentlichen Widerstandsfähigkeit und Regenerationskraft des Herzes von Neugeborenen kann zur Entwicklung neuer Behandlungsstrategien des Herzinfarkts in einer alternden Gesellschaft beitragen.HerzinfarktKindThrombolyseinfantmyocardial infarctionnewbornthrombolytic therapytissue plasminogen activator Neugeborenes

Related Concept Videos

Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
248
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
174
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
164
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
125
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
286
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
611